Fingers crossed. Depends who the company can get in front of. I would love to see some forward guidance given the Chinese approvals and the development of the CPT codes. I think the company is mindful of the share price, there has been a lot of communication lately about maximizing value and moving the company from and R&D phase to a sales phase.
Fingers crossed. Depends who the company can get in front of. I...
Add UCM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.506M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 66058 | 2 |
View Market Depth
| Last trade - 16.12pm 25/11/2024 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable
